Statement by Sung Poblete, PhD, RN, CEO of FARE, Regarding Xolair Receiving FDA Approval for Food Allergies
I am so excited to see that Xolair has been FDA-approved for food allergies. This is a massive win for our community. Patients will now have access to this new treatment opportunity. Thank you to the Genentech and Novartis teams, to the CoFAR sites who facilitated the phase three clinical trial, and most importantly to the brave patients who have volunteered to participate in the study.
Media Contact:
About FARE
FARE (Food Allergy Research & Education) is the nation’s leading non-profit engaged in food allergy advocacy and the largest food allergy charity supporting research. FARE’s innovative education, advocacy and research initiatives transform the future of food allergy through new and improved treatments and prevention strategies, effective policies and legislation, and novel approaches to managing the disease. To learn more, visit: foodallergy.org.